Assessment of regorafenib activity with FDG-PET/CT in a multicenter phase II study in patients (pts) with advanced gastrointestinal stromal tumor (GIST) following failure of standard therapy (Rx).

Phase Ii ◽

Fdg Pet ◽

Standard Therapy ◽

Phase Ii Study ◽

Stromal Tumor ◽

Multicenter Phase ◽

Pet Ct ◽

A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with imatinib (IM) and sunitinib (SU).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.10007 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 10007-10007 ◽

Cited By ~ 9

Author(s):

S. George ◽

M. von Mehren ◽

M. C. Heinrich ◽

Q. Wang ◽

C. L. Corless ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Stromal Tumor ◽

Multicenter Phase

Phase II study to evaluate the efficacy of regorafenib in metastatic colorectal cancer patients by the assessment using FDG-PET/CT (JACCRO CC-12) metastatic colorectal cancer (JACCRO CC-12)

Annals of Oncology ◽

10.1093/annonc/mdw370.72 ◽

2016 ◽

Vol 27 ◽

pp. vi173 ◽

Cited By ~ 1

Author(s):

H. Satake ◽

M. Nakamura ◽

A. Tsuji ◽

T. Sagawa ◽

F. Tamura ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Fdg Pet ◽

Phase Ii Study ◽

Pet Ct ◽

Colorectal Cancer Patients ◽

F-18 FDG PET/CT Assessment of Gastrointestinal Stromal Tumor Response to Sunitinib Malate Therapy

Clinical Nuclear Medicine ◽

10.1097/rlu.0b013e318162dddb ◽

2008 ◽

Vol 33 (3) ◽

pp. 211-212 ◽

Cited By ~ 6

Author(s):

Ignacio Banzo ◽

Remedios Quirce ◽

Isabel Martinez-Rodriguez ◽

Julio Jimenez-Bonilla ◽

Aurora Sainz-Esteban ◽

...

Keyword(s):

Fdg Pet ◽

Tumor Response ◽

Stromal Tumor ◽

Sunitinib Malate ◽

Pet Ct ◽

Inflammatory Myofibroblastic Tumor Mimicking Gastric Gastrointestinal Stromal Tumor on 18F-FDG PET/CT

Clinical Nuclear Medicine ◽

10.1097/rlu.0000000000000392 ◽

2014 ◽

Vol 39 (8) ◽

pp. 725-727 ◽

Cited By ~ 6

Author(s):

Ari Chong ◽

Jung-Min Ha ◽

Ran Hong ◽

Sang-Gon Park ◽

Hee Jeong Lee

Keyword(s):

Fdg Pet ◽

Inflammatory Myofibroblastic Tumor ◽

Stromal Tumor ◽

Pet Ct ◽

18F Fdg ◽

Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study

Annals of Oncology ◽

10.1093/annonc/mdy299.018 ◽

2018 ◽

Vol 29 ◽

pp. viii583

Author(s):

E. Kim ◽

M.-H. Ryu ◽

S.R. Park ◽

M.Y. Beck ◽

W.J. Lee ◽

...

Keyword(s):

Skin Rash ◽

Phase Ii ◽

Phase Ii Study ◽

Steroid Treatment ◽

Stromal Tumor ◽

Systemic Steroid

Primary Extragastrointestinal Stromal Tumor on FDG PET/CT

Clinical Nuclear Medicine ◽

10.1097/rlu.0000000000002200 ◽

2018 ◽

Vol 43 (9) ◽

pp. 702-703 ◽

Cited By ~ 1

Author(s):

Yanyan Zhang ◽

Annan Zhang ◽

Le Song ◽

Xinxin Li ◽

Weifang Zhang

Keyword(s):

Fdg Pet ◽

Stromal Tumor ◽

Extragastrointestinal Stromal Tumor ◽

Pet Ct ◽

Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study

Annals of Oncology ◽

10.1093/annonc/mdz339.023 ◽

2019 ◽

Vol 30 ◽

pp. vi88

Author(s):

Yoichi Naito ◽

Toshihiko Doi ◽

Tsuyoshi Takahashi ◽

Toshihiro Kudo ◽

Narikazu Boku ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Stromal Tumor ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Imatinib Resistant

Phase II study of TAS-116, an oral inhibitor of heat shock protein 90 (HSP90), in metastatic or unresectable gastrointestinal stromal tumor refractory to imatinib, sunitinib and regorafenib

Annals of Oncology ◽

10.1093/annonc/mdx387.006 ◽

2017 ◽

Vol 28 ◽

pp. v322-v323 ◽

Cited By ~ 3

Author(s):

Y. Kurokawa ◽

T. Doi ◽

A. Sawaki ◽

Y. Komatsu ◽

M. Ozaka ◽

...

Keyword(s):

Heat Shock ◽

Heat Shock Protein ◽

Phase Ii ◽

Phase Ii Study ◽

Heat Shock Protein 90 ◽

Stromal Tumor

Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5553 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5553-5553

Author(s):

J. Ley ◽

D. Adkins ◽

D.I. Kuperman ◽

B.A. Siegel ◽

F. Dehdashti ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Fdg Pet ◽

Tumor Response ◽

Phase Ii Study ◽

Response Assessment ◽

Pet Ct ◽

Prospective Phase ◽

Fdg Pet Ct ◽

Recurrent Head

Systemic Steroid Treatment for Imatinib‐Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study

The Oncologist ◽

10.1634/theoncologist.2019-0953 ◽

2020 ◽

Vol 25 (11) ◽

Author(s):

Eo Jin Kim ◽

Min‐Hee Ryu ◽

Sook Ryun Park ◽

Mo Youl Beck ◽

Woo Jin Lee ◽

...

Keyword(s):

Skin Rash ◽

Phase Ii ◽

Phase Ii Study ◽

Steroid Treatment ◽

Stromal Tumor ◽

Systemic Steroid